Tomasz M Beer Selected Research

abarelix (Plenaxis)

10/2006	Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study.
4/2005	Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer.
2/2004	Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.
5/2003	Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomasz M Beer Research Topics

Disease

193	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
85	Neoplasms (Cancer) 05/2022 - 01/2003
21	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2006
17	Disease Progression 01/2022 - 05/2003
14	Carcinoma (Carcinomatosis) 01/2020 - 03/2003
13	Fatigue 01/2022 - 08/2007
12	Pain (Aches) 11/2017 - 06/2002
9	Adenocarcinoma 12/2018 - 01/2002
6	Hypoxia (Hypoxemia) 01/2021 - 06/2011
5	Hypercalcemia (Milk Alkali Syndrome) 04/2007 - 01/2003
4	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 08/2007
4	Diarrhea 01/2022 - 08/2007
4	Neutropenia 01/2020 - 05/2006
4	Breast Neoplasms (Breast Cancer) 12/2018 - 12/2004
4	Anemia 04/2011 - 12/2004
4	Thrombosis (Thrombus) 09/2007 - 02/2006
3	Frailty 11/2021 - 07/2017
3	Febrile Neutropenia 01/2020 - 02/2008
3	Osteoporosis 08/2014 - 12/2006
3	Leukopenia 04/2011 - 08/2007
2	COVID-19 03/2022 - 11/2021
2	Melanoma (Melanoma, Malignant) 12/2020 - 12/2019
2	Margins of Excision 01/2020 - 05/2006
2	Circulating Neoplastic Cells 12/2017 - 09/2017
2	Venous Thromboembolism 11/2017 - 10/2006
2	Bone Diseases (Bone Disease) 10/2016 - 04/2010
2	Cancer Pain 10/2015 - 09/2013

Drug/Important Bio-Agent (IBA)

78	AndrogensIBA 01/2022 - 06/2002
55	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2002
35	enzalutamideIBA 01/2022 - 05/2009
28	Prostate-Specific Antigen (Semenogelase)IBA 12/2021 - 03/2003
22	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2006
21	Calcitriol (Calcijex)FDA LinkGeneric 12/2008 - 01/2003
14	Hormones (Hormone)IBA 01/2022 - 01/2002
14	Prednisone (Sone)FDA LinkGeneric 01/2022 - 04/2003
13	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2017 - 04/2003
10	VA 061 (VA061)IBA 01/2009 - 01/2003
9	Pharmaceutical PreparationsIBA 01/2018 - 01/2003
8	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 01/2003
7	Testosterone (Sustanon)FDA Link 12/2021 - 09/2002
7	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2009
7	Vitamin D FDA LinkGeneric 08/2011 - 12/2004
6	abirateroneIBA 01/2022 - 11/2014
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2006
6	Biological ProductsIBA 04/2016 - 12/2004
5	LigandsIBA 10/2022 - 01/2003
5	C-Reactive ProteinIBA 08/2021 - 06/2008
5	taxaneIBA 01/2021 - 12/2007
5	IpilimumabIBA 12/2020 - 05/2014
5	sipuleucel-T (APC8015)FDA Link 01/2016 - 07/2011
5	Estrogens (Estrogen)FDA Link 06/2008 - 12/2004
4	AntigensIBA 01/2022 - 05/2014
4	Abiraterone AcetateIBA 12/2021 - 11/2014
4	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2011
4	RNA (Ribonucleic Acid)IBA 12/2020 - 08/2017
4	Analgesics (Analgesic Drugs)IBA 09/2013 - 02/2004
4	Hemoglobins (Hemoglobin)IBA 04/2013 - 12/2004
4	Estradiol (Delestrogen)FDA LinkGeneric 04/2010 - 02/2005
4	Follicle Stimulating Hormone (Follitropin)FDA Link 10/2006 - 05/2003
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2006 - 05/2003
4	abarelix (Plenaxis)FDA Link 10/2006 - 05/2003
4	Estramustine FDA Link 09/2005 - 06/2002
3	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 03/2014
3	PlatinumIBA 10/2020 - 02/2008
3	Androgen Receptor AntagonistsIBA 06/2019 - 04/2015
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 01/2017
3	Taxoids (Taxanes)IBA 04/2010 - 02/2008
3	Carboplatin (JM8)FDA LinkGeneric 03/2008 - 10/2004
3	CalciumIBA 07/2007 - 03/2003
3	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2006 - 09/2003
2	ErbB Receptors (EGF Receptor)IBA 10/2022 - 03/2012
2	Circulating Tumor DNAIBA 05/2022 - 12/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 08/2005
2	SteroidsIBA 11/2021 - 09/2007
2	LipidsIBA 08/2021 - 02/2006
2	Cell-Free Nucleic AcidsIBA 07/2021 - 01/2017
2	Hypoxia-Inducible Factor 1IBA 01/2021 - 11/2011
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
2	PanobinostatIBA 04/2019 - 01/2019
2	bicalutamide (Casodex)FDA LinkGeneric 04/2019 - 01/2019
2	Androgen Antagonists (Antiandrogens)IBA 01/2019 - 05/2009
2	Histone Deacetylase InhibitorsIBA 01/2019 - 11/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2018 - 12/2006
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017 - 07/2005
2	Lysine (L-Lysine)FDA Link 05/2015 - 11/2011
2	Everolimus FDA Link 04/2015 - 04/2011

Therapy/Procedure

98	Therapeutics 01/2022 - 06/2002
82	Castration 01/2022 - 11/2007
59	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
18	Prostatectomy (Retropubic Prostatectomy) 12/2021 - 03/2003
10	Radiotherapy 01/2022 - 08/2005
7	Immunotherapy 01/2022 - 07/2011
6	Resistance Training 03/2022 - 03/2012
6	Neoadjuvant Therapy 01/2014 - 05/2006
3	Aftercare (After-Treatment) 11/2021 - 02/2013
3	Chemoprevention 01/2017 - 12/2004
3	Intramuscular Injections 10/2006 - 05/2003
2	Orchiectomy (Orchidectomy) 11/2021 - 02/2004
2	Drug Tapering 01/2019 - 04/2010
2	Life Support Care 10/2015 - 11/2014